head uk2

Reviews and publications with chitosan in 2023

Numerous publications on the topic of chitosan were published again last year. It was observed that the number increased again compared to the previous year. While a total of 3097 publications with chitosan in the title were published in 2022, there were over 300 more publications in 2023 with 3409. We at HMC are very excited about this!

Of the 3409 search results (PubMed, as of 12.02.2024), 213 were reviews. The top 3 journals were the International Journal of Biological Macromolecules (56 reviews), Carbohydrate Polymers (24 reviews) and Polymers (Basel) (23 reviews). Reviews were published on a wide variety of topics such as nanoparticles/nanofibers (52), drug transport (24), hydrogels (31) and wound treatment (7). In the following, we would like to briefly present three of the reviews on different topics:

Thambiliyagodage, C.; Jayanetti, M.; Mendis, A.; Ekanayake, G.; Liyanaarachchi, H.; Vigneswaran, S. Recent Advances in Chitosan-Based Applications—A Review. Materials 2023, 16, 2073.

In their review, Thambiliyagodage et al. provide an overview of the latest developments of chitosan-based applications in areas such as drug delivery, dentistry, ophthalmology, wound dressing, cell encapsulation, bioimaging or tissue engineering. The advantages and disadvantages of using chitosan and chitosan derivatives in the above-mentioned applications are explained in this review and the main challenges and future prospects are discussed in detail.

Beleño Acosta, B.; Advincula, R.C.; Grande-Tovar, C.D. Chitosan-Based Scaffolds for the Treatment of Myocardial Infarction: A Systematic Review. Molecules 2023, 28, 1920.

The review by Acosta et al. systematically summarizes and evaluates the literature of the last 5 years on the production and application of chitosan scaffolds for the reconstruction of myocardial tissue. It was found that chitosan is particularly suitable for the reconstruction of myocardial tissue by mimicking the physiological environment with a controlled porosity that enables the exchange of nutrients, the improvement of electrical conductivity and the stimulation of cell differentiation of stem cells.

Al-Absi MY, Caprifico AE, Calabrese G. Chitosan and Its Structural Modifications for siRNA Delivery. Adv Pharm Bull. 2023 Mar;13(2):275-282. doi: Epub 2022 Jan 8. PMID: 37342385; PMCID: PMC10278227.

In their review, Al-Absi et al. describe various chemical and non-chemical chitosan derivatives to improve the transport of siRNA, as conventional chitosan has some limitations such as limited solubility at physiological pH. Besides the type of modifications, chemical structure, physiochemical properties or siRNA binding properties of the derivatives, the properties of the resulting nanoparticles were analyzed and the choice of modifications was discussed.

chitosan, Publications, Reviews, research, chitosan derivatives

Congress and fairs

Meet us in person 2024:

  • 14th PBP World Meeting/ Research Pharm, Vienna, Austria, 18.-21.03.2024
  • EPNOE Workshop on Analytics of Polysaccharides, ETH Zürich, Zürich, Switzerland, 25.-26.06.2024
  • CPHI, Milan, Italy, 08.-10.10.2024
  • MEDICA 2024, Düsseldorf, Germany, 11.-14.11.2024

To arrange an appointment please contact Katja Richter via This email address is being protected from spambots. You need JavaScript enabled to view it.


  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
Contact | GTC / Terms of Use | Legal info | Copyright © 2024 Heppe Medical Chitosan GmbH | Privacy notice

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.